BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25534010)

  • 1. Multifunctional radiolabeled nanoparticles: strategies and novel classification of radiopharmaceuticals for cancer treatment.
    Enrique MA; Mariana OR; Mirshojaei SF; Ahmadi A
    J Drug Target; 2015 Apr; 23(3):191-201. PubMed ID: 25534010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabelled nanoparticles: novel classification of radiopharmaceuticals for molecular imaging of cancer.
    Mirshojaei SF; Ahmadi A; Morales-Avila E; Ortiz-Reynoso M; Reyes-Perez H
    J Drug Target; 2016; 24(2):91-101. PubMed ID: 26061297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer.
    Hamoudeh M; Kamleh MA; Diab R; Fessi H
    Adv Drug Deliv Rev; 2008 Sep; 60(12):1329-46. PubMed ID: 18562040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy.
    Ting G; Chang CH; Wang HE
    Anticancer Res; 2009 Oct; 29(10):4107-18. PubMed ID: 19846958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular nanomedicine towards cancer: ¹¹¹In-labeled nanoparticles.
    Psimadas D; Georgoulias P; Valotassiou V; Loudos G
    J Pharm Sci; 2012 Jul; 101(7):2271-80. PubMed ID: 22488174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear imaging in cancer theranostics.
    Del Vecchio S; Zannetti A; Fonti R; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):152-63. PubMed ID: 17420716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.
    D'Huyvetter M; Xavier C; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
    Expert Opin Drug Deliv; 2014 Dec; 11(12):1939-54. PubMed ID: 25035968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches for imaging and therapy of solid cancer.
    Sollini M; Boni R; Traino AC; Lazzeri E; Pasqualetti F; Modeo L; Mariani G; Petrini M; Erba PA
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):168-83. PubMed ID: 25693421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo targeted delivery of nanoparticles for theranosis.
    Koo H; Huh MS; Sun IC; Yuk SH; Choi K; Kim K; Kwon IC
    Acc Chem Res; 2011 Oct; 44(10):1018-28. PubMed ID: 21851104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
    Shi J; Xiao Z; Kamaly N; Farokhzad OC
    Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostic nanoparticles.
    Chen F; Ehlerding EB; Cai W
    J Nucl Med; 2014 Dec; 55(12):1919-22. PubMed ID: 25413134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?
    Pant K; Sedláček O; Nadar RA; Hrubý M; Stephan H
    Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28218487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipid-soluble complexes in targeted tumor therapy.
    Thakur ML; Coss R; Howell R; Vassileva-Belnikolovska D; Liu J; Rao SP; Spana G; Wachsberger P; Leeper DL
    J Nucl Med; 2003 Aug; 44(8):1293-300. PubMed ID: 12902421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy in nuclear medicine--current status and future prospects.
    Oyen WJ; Bodei L; Giammarile F; Maecke HR; Tennvall J; Luster M; Brans B
    Ann Oncol; 2007 Nov; 18(11):1782-92. PubMed ID: 17434893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles.
    Phillips WT; Bao A; Brenner AJ; Goins BA
    Adv Drug Deliv Rev; 2014 Sep; 76():39-59. PubMed ID: 25016083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide cancer therapy.
    Hoefnagel CA
    Ann Nucl Med; 1998 Apr; 12(2):61-70. PubMed ID: 9637275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy.
    Aerts A; Impens NR; Gijs M; D'Huyvetter M; Vanmarcke H; Ponsard B; Lahoutte T; Luxen A; Baatout S
    Curr Pharm Des; 2014; 20(32):5218-44. PubMed ID: 24606796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface Engineering of Nanoparticles toward Cancer Theranostics.
    Huang P; Wang C; Deng H; Zhou Y; Chen X
    Acc Chem Res; 2023 Jul; 56(13):1766-1779. PubMed ID: 37314368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles for SPECT and PET Imaging: Towards Personalized Medicine and Theranostics.
    Polyak A; Ross TL
    Curr Med Chem; 2018; 25(34):4328-4353. PubMed ID: 28875837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide radiopharmaceuticals for diagnosis and therapy.
    Signore A; Annovazzi A; Chianelli M; Corsetti F; Van de Wiele C; Watherhouse RN
    Eur J Nucl Med; 2001 Oct; 28(10):1555-65. PubMed ID: 11685500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.